Peer Review of “Early Experience With Neutralizing Monoclonal Antibody Therapy for COVID-19: Retrospective Cohort Survival Analysis and Descriptive Study”
Format: | Article |
---|---|
Language: | English |
Published: |
JMIR Publications
2021-09-01
|
Series: | JMIRx Med |
Online Access: | https://med.jmirx.org/2021/3/e33499 |
Similar Items
-
Early Experience With Neutralizing Monoclonal Antibody Therapy for COVID-19: Retrospective Cohort Survival Analysis and Descriptive Study
by: Mark Jarrett, et al.
Published: (2021-09-01) -
Authors' Response to Peer Reviews of “Early Experience With Neutralizing Monoclonal Antibody Therapy for COVID-19: Retrospective Cohort Survival Analysis and Descriptive Study”
by: Mark Jarrett, et al.
Published: (2021-09-01) -
Neutralizing monoclonal antibodies for treatment of COVID-19
by: Taylor, PC, et al.
Published: (2021) -
Status and Developing Strategies for Neutralizing Monoclonal Antibody Therapy in the Omicron Era of COVID-19
by: Zuning Ren, et al.
Published: (2023-05-01) -
Unclassifiable Isolated Monoclonal Lymphocytosis: Comprehensive Description of a Retrospective Cohort
by: Michaël Degaud, et al.
Published: (2019-10-01)